Amedica, which sells a broad range of medical devices using its silicon nitride technology platform, announced terms for its IPO on Wednesday. The Salt Lake City, UT-based company plans to raise $35 million by offering 3.2 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Amedica would command a fully diluted market value of $143 million.
Amedica, which was founded in 1996 and booked $23 million in sales for the 12 months ended September 30, 2013, plans to list on the NASDAQ under the symbol AMDA. Amedica initially filed confidentially on September 23, 2013. JMP Securities is the sole bookrunner on the deal.